Petra Sicher
About Petra Sicher
Petra Sicher is the Associate Director Molecule Quality Lead at Bristol Myers Squibb, with extensive experience in Good Clinical Practice (GCP) auditing and medical roles.
Company
Petra Sicher is currently employed at Bristol Myers Squibb. She serves as the Associate Director Molecule Quality Lead at the leading biopharmaceutical company. Bristol Myers Squibb focuses on developing innovative medicines for serious diseases, and Petra’s role is integral to ensuring the quality of these medicines.
Title
Petra Sicher holds the position of Associate Director Molecule Quality Lead. She has been in this role since January 2021. Her responsibilities likely include overseeing the quality of various molecules throughout their development process and ensuring compliance with industry standards.
Previous Roles at Bristol Myers Squibb
Before her current role, Petra Sicher worked as a Senior GCP Auditor at Bristol Myers Squibb from 2016 to 2021. During her tenure, she was based in Boudry, Switzerland, where she spent five years ensuring Good Clinical Practice (GCP) compliance for the organization’s clinical trials.
Good Clinical Practice (GCP) Auditing Experience
Petra Sicher has a wealth of experience in GCP auditing, having held multiple auditor roles at different organizations. She served as a GCP Auditor for the European Thoracic Oncology Platform (ETOP) from 2011 to 2016 and at the International Breast Cancer Study Group (IBCSG) from 2010 to 2016. This extensive background underscores her expertise in maintaining compliance and quality in clinical trials.
Medical Doctor Roles
In her early career, Petra Sicher worked as a Medical Doctor. She served at Private Clinic Wyss in Münchenbuchsee from 2005 to 2007 and at Canton Hospital Schaffhausen from 2003 to 2005. These roles provided her with hands-on medical experience and a deep understanding of patient care.
Research Fellow in Rheumatology
Petra Sicher conducted research as a Research Fellow in Rheumatology at Inselspital Bern from 2001 to 2003. During her two years in this position, she contributed to advancing medical knowledge in the field of rheumatology.